Daniella Schwartz is a Rheumatology/Immunology physician affiliated with University of Pittsburgh. OpenAlex indexes 115 publications with 8,745 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 5th Ave Ste 2b
Pittsburgh, PA 152133403
Telephone
412-647-6700Provider last certified this registry record 6 Jul 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SOBI, INCProgram year202521 payments$24,117openpaymentsdata.cms.gov ↗
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
63.2%TNF inhibitor24.2%Humira(Cf)52%Remicade48%Part D<11 patientsInterleukin-1 Receptor Antagonist14.7%Kineret100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
36.8%Corticosteroid36.8%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:
- Developing a Molecular Taxonomy for Immune-Mediated Diseases
University of Pittsburgh at Pittsburgh
FY2026$641,889R01AI189495
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recognizing and Managing Secondary Hemophagocytic Lymphohistiocytosis in Adults
Hematology/Oncology Clinics of North America
2025 - The Complexity of Being A20: From Biological Functions to Genetic Associations
Journal of Clinical Immunology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”